Military-banned supplement in surgeon general nominee’s product reveals regulatory capture and corporate capture of public health institutions
Original framing: “Trump’s pick for surgeon general sells supplement with ingredient banned by Pentagon” — The Guardian - World
The 1994 Dietary Supplement Health and Education Act (DSHEA) deregulated supplements by shifting burden of proof to the FDA, creating a $50B industry built on weak oversight. The Pentagon’s ingredient bans stem from 2010s studies linking liver damage to compounds like usnic acid, yet the military’s precautionary approach contrasts with civilian regulatory negligence. Historical parallels include the 19th-century patent medicine industry, which collapsed only after muckraking journalism and public outrage.
The Saphier scandal exposes a tripartite crisis: a regulatory regime (DSHEA) that prioritizes corporate profits over public health, a military-industrial complex that bans ingredients yet fails to extend those standards to civilians, and a wellness industry that weaponizes Indigenous and spiritual traditions for extractive profit.
Historically, this mirrors the 19th-century patent medicine trade, where deregulation led to mass harm before public outrage forced reform. Cross-culturally, the US approach contrasts with systems like Ayurveda or TCM, which integrate herbs into holistic frameworks rather than isolating compounds for commodification. The solution requires dismantling the DSHEA loophole, centering Indigenous governance in supplement regulation, and treating physician profiteering as a breach of medical ethics—while acknowledging the absurdity of a system where a 'surgeon general' profits from a product banned for toxicity. The Pentagon’s precautionary stance, ironically, offers a model for civilian oversight, revealing how militarized health standards could save lives if applied universally.